ReferenceGrowth-hormone secretagogue research
Hexarelin
Examorelin · HEX · hexapeptide secretagogue
Potent ghrelin-receptor secretagogue studied in GH-release and cardiac research.
About Hexarelin
Hexarelin is a synthetic hexapeptide ghrelin-receptor agonist studied for potent growth-hormone release and for CD36-mediated effects in cardiovascular-research models. It is a reference secretagogue alongside the GHRPs. TagPep is adding hexarelin as a research-use-only reference material.
Mechanism studied in research
Agonism at the ghrelin/GHS receptor and interaction with CD36 — pathways studied for GH release and cardiac tissue in model systems.
Areas of research investigation
- GH-secretagogue assays
- Cardiovascular research models
- CD36-signaling studies
- Comparative secretagogue potency
Laboratory handling
Lyophilized; reconstituted with bacteriostatic or sterile water for research and refrigerated; powder frozen and light-protected.
Hexarelin research FAQ
How does hexarelin compare to the GHRPs?
Hexarelin is a potent ghrelin-receptor secretagogue in the same functional family as GHRP-2 and GHRP-6, and is also studied for CD36-mediated cardiovascular effects.
Is hexarelin available now?
It is on the research roadmap. Contact TagPep to be notified when a documented batch is released.
Research use only. Hexarelin is supplied as a laboratory reference material for in-vitro and research applications. It is not a drug, supplement or medical product, and is not intended for human or veterinary use, consumption, or clinical application.